WPE_6899_460x337.jpg

Publication

You are here:

Publications

Selected references

Kopp MA, Watzlawick R, Martus P, Failli V, Finkenstaedt FW, Chen Y, DeVivo MJ, Dirnagl U, Schwab JM. Long-term functional outcome in patients with acquired infections after acute spinal cord injury. Neurology. 2017 Feb 28;88(9):892-900.

Kopp MA, Liebscher T, Watzlawick R, Martus P, Laufer S, Blex C, Schindler R, Jungehulsing GJ, Knüppel S, Kreutzträger M, Ekkernkamp A, Dirnagl U, Strittmatter SM, Niedeggen A, Schwab JM. SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol. BMJ Open. 2016 Jul 26;6(7):e010651.

Brommer B, Engel O, Kopp MA, Watzlawick R, Müller S, Prüss H, Chen Y, DeVivo MJ, Finkenstaedt FW, Dirnagl U, Liebscher T, Meisel A, Schwab JM. Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. Brain. 2016 Mar;139(Pt 3):692-707.

Watzlawick R., Sena E.S., Dirnagl U., Brommer B., Kopp M.A., Macleod M.R., Howells D.W., Schwab J.M. (2014) Effect and Reporting Bias of RhoA/ROCK-Blockade Intervention on Locomotor Recovery After Spinal Cord Injury: A Systematic Review and Meta-analysis. JAMA Neurol., 71:91-9.

Kopp M.A., Druschel C., Meisel C., Liebscher T., Prilipp E., Watzlawick R., Cinelli P., Niedeggen A., Schaser K.D., Wanner G.A., Curt A., Lindemann G., Nugaeva N., Fehlings M.G., Vajkoczy P., Cabraja M., Dengler J., Ertel W., Ekkernkamp A., Martus P., Volk H.D., Unterwalder N., Kölsch U., Brommer B., Hellmann R.C., Ossami Saidy R.R., Laginha I., Prüss H., Failli V., Dirnagl U., Schwab J.M. (2013) The SCIentinel study - prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS) - study protocol and interim feasibility data. BMC Neurol., 13:168.

Failli V., Kopp M.A., Gericke C., Martus P., Klingbeil S., Brommer B., Laginha I., Chen Y., DeVivo M.J., Dirnagl U., Schwab J.M. (2012) Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain, 135:3238-50.

Prüss H., Iggena D., Baldinger T., Prinz V., Meisel A., Endres M., Dirnagl U., Schwab J.M. (2012) Evidence for intrathecal antibody synthesis in stroke – a cohort study. Arch. Neurol., 69:714-7.

Mirakaj V, Brown S, Laucher S, Steinl C, Klein G, Köhler D, Skutella T, Meisel C, Brommer B, Rosenberger P, Schwab JM (2011) RGM-A inhibits leukocyte migration and mitigates inflammation. Proc Natl Acad Sci USA, 108:6555-60

Prüss H, Kopp M, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM (2011) Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol, 21:652-60

Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10:195-202

Schwab JM, Chiang N, Arita M, Serhan CN. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869-874

Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. 2005. Central nervous system injury-induced immune deficiency syndrom. Nat Rev Neurosci 6:675-686

Schwab JM, Brechtel K, Mueller CA, Failli V, Kaps HP, Tuli SK, Schluesener HJ. 2006. Experimental strategies to promote spinal cord regeneration-an integrative perspective. Prog Neurobiol 78:91-116

Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, Gerstein J, Dietz K, Abdizahdeh M, Schwab JM. 2008. Immune depression syndrome following human spinal cord injury: A pilot study. Neuroscience 158:1194-1199

Riegger T, Conrad S, Liu K, Schluesener HJ, Abdibzahdeh M, Schwab JM. 2007. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci 25:1743-1747

Schwab JM, Conrad S, Monnier PP, Julien S, Mueller BK, Schluesener HJ. 2005. Spinal cord injury induced lesional expression of the repulsive guidance molecule (RGM). Eur J Neurosci 21:1569-1576

Schwab JM, Failli V, Chédotal A. 2005. Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system. Lancet 365: 2055-2057.

Schwab JM, Schluesener HJ, Laufer S. 2003. COX-3: just another COX or the solitary elusive target of paracetamol. Lancet 361:981-982

Schwab JM, Frei E, Klusmann I, Schnell L, Schwab ME, Schluesener HJ. 2001. AIF-expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J Neuroimmunol 119:214-222